在罕见疾病中模型信息化药物开发的新视野 药物开发 药物开发
Amitava Mitra1, Nessy Tania2, Mariam A Ahmed3
1Clinical Pharmacology, Kura Oncology Inc., Boston, Massachusetts, USA.
Clinical pharmacology and therapeutics
|July 11, 2024
概括
基于模型的方法通过整合数据来增强风险效益概况来增强药物开发,特别是在有限的患者群体中转变罕见病药物开发.
科学领域:
- 药量计学和定量药理学
- 药物开发和监管科学 药物开发和监管科学
- 罕见疾病研究研究 罕见疾病研究
背景情况:
- 基于模型的方法为在药物开发中整合各种数据提供了定量框架.
- 最大限度地利用数据可以提高风险效益评估,减少不确定性.
- 这些方法对于罕见疾病至关重要,因为传统的试验具有挑战性.
研究的目的:
- 讨论新型定量方法在药物开发中的应用.
- 展示罕见疾病中这些建模方法的案例研究.
- 分享关于这些工具在罕见疾病药物开发中的未来的观点.
主要方法:
- 量化系统药理学 药理学
- 疾病进展建模的模型.
- 人工智能和机器学习
- 现实世界的数据建模 (基于模型的元分析)
- 外部对照和患者报告的结果
- 临床试验模拟的临床试验模拟
主要成果:
- 基于模型的方法提供了一系列证据,以进行可靠的风险-收益表征.
- 这些方法可以在没有额外的临床数据的情况下支持监管部门的批准.
- 案例研究表明,在罕见疾病中成功应用了药物开发.
结论:
- 基于模型的方法对罕见疾病的药物开发具有变革性.
- 这些定量工具优化试验,减少不确定性,并支持监管决策.
- 未来有机会将这些方法纳入合理的药物产品开发中.
相关概念视频
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Prescription, Nonprescription and Orphan Drugs
714
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
714
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


